FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Richardson Kevin A II		 2. Issuer Name and Ticker or Trading Symbol

SANUWAVE Health, Inc. [ SNWW ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Executive Officer
(Last)          (First)          (Middle)

100 CUMMINGS CENTER, SUITE 332D		 3. Date of Earliest Transaction (MM/DD/YYYY)

1/30/2020
(Street)

BEVERLY, MA 01915
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options $0.20 1/30/2020  A   5200000 (1)    (2)12/31/2022 Common Stock, $0.01 par value 5200000 $0 5200000 D  
Explanation of Responses:
(1) The Company does not have sufficient authorized shares available for the issuance of shares of Common Stock upon the exercise of the Option, but the Company plans to seek shareholder approval of an increase in its authorized shares of Common Stock at this year's annual meeting of stockholders.
(2) Subject to the recipient's continued service and, all of the shares subject to the Option shall vest and become exercisable on the date on which the ten day average trading price for a share of the Company's Common Stock equals or exceeds $0.60 on or before December 31, 2022. If the forgoing condition has not been achieved on or before December 31, 2022, the Option shall be forfeited and cancelled as of December 31, 2022.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Richardson Kevin A II
100 CUMMINGS CENTER
SUITE 332D
BEVERLY, MA 01915		X
Chief Executive Officer
Signatures
/s/ Kevin A. Richardson II2/25/2020
**Signature of Reporting PersonDate
Grafico Azioni SANUWAVE Health (QB) (USOTC:SNWV)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di SANUWAVE Health (QB)
Grafico Azioni SANUWAVE Health (QB) (USOTC:SNWV)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di SANUWAVE Health (QB)